41 – 50 of 255
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
(
- Contribution to journal › Scientific review
-
Mark
Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
2021) European Respiratory Society (ERS) congress 2021(
- Contribution to conference › Poster
-
Mark
Risk of Rehospitalization and Death in Patients Hospitalized Due to Asthma
(
- Contribution to journal › Article
-
Mark
Efficacy of mepolizumab in usual clinical practice and characteristics of responders : Mepolizumab in usual clinical practice
(
- Contribution to journal › Article
-
Mark
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma
(
- Contribution to journal › Article
-
Mark
Use of fractional exhaled nitric oxide to guide the treatment of asthma an official american thoracic society clinical practice guideline
(
- Contribution to journal › Article
- 2020
-
Mark
The risk of osteoporosis in patients with asthma
(
- Contribution to journal › Scientific review
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter
-
Mark
A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
(
- Contribution to journal › Article